Search

[Objective] To research the effects of volatile components of Modified Wendan Decoction on improving the behavior of autistic rats. [Methods] Pregnant rats were randomly divided into two groups. On 12.5 d after pregnancy, intraperitoneal injection of 600 mg/kg VPA was carried out so as to establish autistic rats model. In control group, the same volume of 0.85% normal saline (NS) was intraperitoneal injected. The auxanology, behavior and morphology identification of rats were carried out. A total of 60 autistic rats and 20 rats in NS group were randomly collected on the 35th day after pregnancy. And autistic rats were randomly divided into distilled water group (DW), Modified Wendan Decoction group (VPA-1) and Modified Wendan Decoction and volatile oil group (VPA-2). There were 20 rats in each group. The volatile components of Modified Wendan Decoction were analyzed by steam distiilation method (SD) and GC-MS. [Results] VPA-1 group improved the behavior of autistic rats in certain degrees, but the effects were poorer than VPA-2 group. A total of 71 volatile components were detected. Among them, α-asarone, D-limonene and eugenol had relatively high content, accounting for 99.89% of the total volatile components. [Results] The volatile oils in Modified Wendan Decoction enhanced the therapeutic effects of autism. Literatures showed that α-asarone, D-limonene, eugenol and other volatile components adjusted the central nervous system, improved cerebral function, had the functions of anticonvulsion, anti-epileptic and diazepam, and improved the symptoms of autism. This research provided methodological basis for the analysis of volatile components in Modified Wendan Decoction, and provided references for the medicinal efficacy research on curing autism. [ABSTRACT FROM AUTHOR]

[Objective] To establlsh rapid analysis method for the volatile components in FOLIUM ARTEMISIA ARGYI, and to research the contents and distribution characteristics of volatile components in FOLIUM ARTEMISIA ARGYI grown in different areas. [Methods] Volatile components in FOLIUM ARTEMISIA ARGYI were analyzed by HS-SPME/GC-MS. Relative content of each component was calculated by peak area normalization method. Data were analyzed by principal component analysis and cluster analysis. [Results] A total of 84 chemical components were preliminarily identified, which were mainly the ketones, alkenes and alcohols. There were certain differences in the volatile components of FOLIUM ARTEMISIA ARGYI. Principal component analysis and cluster analysis could effectively isolate the FOLIUM ARTEMISIA ARGYI gown in different areas. [Conclusions] This method was stable and reliable, which could be used for the rapid analysis of the volatile components in FOLIUM ARTEMISIA ARGYI, and provided certain scientific references for the quality evaluation of the volatile components in FOLIUM ARTEMISIA ARGYI. [ABSTRACT FROM AUTHOR]

Introduction: The objective of this review is to systematically evaluate the effectiveness of moxibustion for treating allergic rhinitis (AR). Methods and analysis: The following databases will be searched from their inception to January 2015: MEDLINE, EMBASE, CINAHL, AMED, Web of Science, Ovid Healthstar, PubMed, SciELO, the China National Knowledge Infrastructure Database, the Chongqing VIP Chinese Science and Technology Periodical Database, the Chinese Biomedical Database, the Wanfang Database, the Japanese Medical Research Database, and Korean Medical Databases. The methodological quality will be assessed using the Cochrane risk of bias tool. The primary outcome is total nasal symptoms, which may be evaluated by any appropriate scores or other forms of measurement. Secondary outcome measures will include quality of life, total non-nasal symptoms, use of daily medication and laboratory indicators. Ethics and dissemination: Because this study will not involve patients, institutional review body permission is not required. The systematic review will be published in a peer-reviewed journal. The review will also be disseminated electronically and in print to help guide healthcare practice and policy. Trial registration number: PROSPERO CRD42014013275. [ABSTRACT FROM AUTHOR]

[Objective] To establish the HPLC fingerprint of flavonoids from SEMEN TRIGONELLAE extracts. [Methods] ZORBAX SB-C18 chromatographic column (4.6 mm X 250 mm, 5 pm) was adopted; based on gradient elution, mobile phase was methanol - 0.4% phosphoric acid solution. Flow rate was 0.8 mILmin; detection wavelength was 339 nm; and injection volume was 10 pL. A total of 10 batches of SEMEN TRIGONELLAE extracts were measured by HPLC with vitexin as the reference substances. [Results] The common mode of the HPLC fingerprints was established; and a total of 11 common peaks were marked. The similarity degrees of the 10 batches of samples were all greater than 0.9. [Conclusions] This method was simple, accurate and repeatable, and provided scientific basis for the quality control standard and quality evaluation of SEMEN TRIGONELLAE extracts. [ABSTRACT FROM AUTHOR]

[Objective] To analyze the composition and content of volatile components in Semen Cassiae. [Methods] The volatile components were extracted with headspace solid phase micro extraction ( HS-SPME), and their content and name were confirmed by GC-MS. [Results] 54 chromatographic peaks were isolated from volatile components of Semen Cassiae, and 31 kinds of compounds were identified, accounting for 51. 96% of total volatile substances. [Conclusions] HS-SPME-GC-MS technology was used to analyze volatile components of Semen Cassiae, which can provide a reference for further development and use of Semen Cassiae. [ABSTRACT FROM AUTHOR]